The rate of twin deliveries increased with increasing body mass index (BMI), and part of this association was explained by higher use of assisted reproductive technology (ART), according to a study published online Jan. 9 ...
Jan 12, 2024
0
0
Researchers at The University of Texas at El Paso have identified a novel pharmaceutical compound that successfully kills leukemia and lymphoma cancer cells, potentially paving the way for new forms of therapy.
Jan 12, 2024
0
146
Extracts of a plant used in traditional medicine for centuries have shown anti-proliferative effects against breast cancer in a small early-stage clinical trial.
Jan 11, 2024
0
80
Do you have family members or friends sick with a respiratory infection? If so, there's a good chance it's COVID, caused by the JN.1 variant currently circulating in Australia.
Jan 11, 2024
0
0
Thirty years ago, Gail Sonenshein was studying cancer in immune cells when she read an article in the New York Times that would shape the rest of her career. The article described a new residency program in women's health, ...
Jan 9, 2024
0
0
Humans are protected by two branches of the immune system. Innate immunity provides built-in defense against widespread characteristics of bacteria and viruses, while adaptive immunity memorizes individual pathogens that ...
Jan 9, 2024
0
36
US regulators on Friday approved Florida's plan to import prescription drugs from Canada, making it the first state to win such authorization, in a bid to lower costs for American consumers.
Jan 6, 2024
0
11
Lisocabtagene maraleucel (liso-cel), a chimeric antigen receptor (CAR) T-cell therapy, is cost-effective for second-line diffuse large B-cell lymphoma (DLBCL) therapy, according to a study published online Dec. 28 in Blood ...
Jan 4, 2024
0
0
Few randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in the Journal of Dermatological Treatment.
Jan 1, 2024
0
0
Elevated levels of high-density lipoprotein cholesterol (HDL-C) are associated with an increased risk for all-cause dementia, according to a study published online Nov. 29 in The Lancet Regional Health: Western Pacific.
Jan 1, 2024
0
58
